Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. between January 18, 2023 and June 25, 2024, both dates inclusive (the "Class Period"), of the ...

Cartesian Therapeutics is a clinical-stage company developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T in Phase 2b ...

Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart’s next generation oral pill COVID-19 vaccine compared to an approved mRNA vaccine comparator — — The sentinel cohort is ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Moderna, Inc. (NASDAQ:MRNA) have reached a stipulation in their ongoing ...

CAMBRIDGE, MA / ACCESSWIRE / October 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that Abbas Hussain, former Chief ...

马萨诸塞州剑桥市 - mRNA疗法和疫苗领域的先驱Moderna Inc (NASDAQ:MRNA)今日宣布，前Vifor Pharma首席执行官和葛兰素史克制药和疫苗全球总裁Abbas Hussain已被任命为公司董事会成员。

Let the good times roll. The S&P 500 has soared nearly 21% in 2024, including a 2% gain in September. What's especially noteworthy is that the bull market has broadened to include more than only ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...

Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart's next generation oral pill COVID-19 vaccine compared to an approved mRNA vaccine comparator ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies ...

马萨诸塞州剑桥市 - Moderna Inc (NASDAQ:MRNA) 已启动其诺如病毒疫苗候选物的3期临床试验，这标志着解决该病毒所带来的广泛公共卫生问题迈出了重要一步。今天，美国第一位参与者接受了疫苗候选物mRNA-1403的剂量，作为Nova ...